Updated

Updated · Bloomberg · Jul 10

Bayer Sells $3.4 Billion Contraceptives Stake to Apollo as It Seeks Stronger Capital Structure

Updated

Updated · Bloomberg · Jul 10

Bayer Sells $3.4 Billion Contraceptives Stake to Apollo as It Seeks Stronger Capital Structure

1 articles · Updated · Bloomberg · Jul 10

€3 billion ($3.4 billion) from Apollo will go toward improving Bayer’s capital structure after the German group sold a minority stake in its contraceptives business.
Bayer said it will retain full operational control of the pharma unit, which sells long-acting reversible contraceptives to patients.
The deal lets Bayer raise fresh funds without giving up control of the business, underscoring a balance-sheet-focused approach rather than a full divestment.